Financhill
Sell
20

EXK Quote, Financials, Valuation and Earnings

Last price:
$3.6800
Seasonality move :
33.75%
Day range:
$3.6350 - $3.8200
52-week range:
$1.4200 - $5.6700
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.80x
P/B ratio:
2.36x
Volume:
10.1M
Avg. volume:
6.4M
1-year change:
89.29%
Market cap:
$973.2M
Revenue:
$205.5M
EPS (TTM):
-$0.13
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $117.4M $138.5M $165.3M $210.2M $205.5M
Revenue Growth (YoY) -21.98% 17.92% 19.4% 27.12% -2.24%
 
Cost of Revenues $134.8M $111.1M $129M $158.6M $168.9M
Gross Profit -$17.4M $27.3M $36.4M $51.5M $36.6M
Gross Profit Margin -14.79% 19.74% 22% 24.52% 17.82%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.7M $12.5M $9.9M $15M $17.9M
Other Inc / (Exp) -$4.1M $672K $23.6M $2.1M $10.5M
Operating Expenses $22.2M $28.1M $29.6M $27.9M $28.1M
Operating Income -$39.6M -$743K $6.8M $23.7M $8.6M
 
Net Interest Expenses $394K $983K $723K $821K $822K
EBT. Incl. Unusual Items -$44M -$1.1M $29.7M $24.9M $18.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $4.1M -$2.2M $15.7M $18.7M $12.1M
Net Income to Company -$48.1M $1.2M $14M $6.2M $6.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$48.1M $1.2M $14M $6.2M $6.1M
 
Basic EPS (Cont. Ops) -$0.36 $0.01 $0.08 $0.03 $0.03
Diluted EPS (Cont. Ops) -$0.36 $0.01 $0.08 $0.03 $0.03
Weighted Average Basic Share $135.4M $150.9M $167.3M $183M $196M
Weighted Average Diluted Share $135.4M $154M $170.7M $185.3M $197.8M
 
EBITDA -$11.6M $28.7M $54.9M $51.8M $47.9M
EBIT -$43.6M -$136K $30.4M $25.7M $19.1M
 
Revenue (Reported) $117.4M $138.5M $165.3M $210.2M $205.5M
Operating Income (Reported) -$39.6M -$743K $6.8M $23.7M $8.6M
Operating Income (Adjusted) -$43.6M -$136K $30.4M $25.7M $19.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $35.6M $34.6M $39.6M $49.4M $53.4M
Revenue Growth (YoY) 28.74% -2.88% 14.72% 24.67% 8.11%
 
Cost of Revenues $29.3M $26.3M $34.5M $46.7M $41M
Gross Profit $6.3M $8.3M $5.1M $2.7M $12.5M
Gross Profit Margin 17.68% 23.95% 12.94% 5.45% 23.36%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.7M -$552K $2.1M $2.3M $3.9M
Other Inc / (Exp) $1.6M -$4.4M $3.3M $4.9M -$16.6M
Operating Expenses $5.9M $4.5M $6.4M $6.5M $8.7M
Operating Income $393K $3.8M -$1.3M -$3.8M $3.8M
 
Net Interest Expenses $359K $195K $311K $316K $509K
EBT. Incl. Unusual Items $1.6M -$803K $1.7M $810K -$13.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.2M $3.7M $3.2M $3.1M $4M
Net Income to Company $451K -$4.5M -$1.5M -$2.3M -$17.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $451K -$4.5M -$1.5M -$2.3M -$17.3M
 
Basic EPS (Cont. Ops) -- -$0.03 -$0.01 -$0.01 -$0.07
Diluted EPS (Cont. Ops) -- -$0.03 -$0.01 -$0.01 -$0.07
Weighted Average Basic Share $156.3M $170.4M $189.2M $194.2M $246M
Weighted Average Diluted Share $156.3M $170.4M $189.2M $194.2M $246M
 
EBITDA $10.3M $4.4M $8.1M $10.2M -$5.4M
EBIT $2M -$608K $2.1M $1.1M -$12.8M
 
Revenue (Reported) $35.6M $34.6M $39.6M $49.4M $53.4M
Operating Income (Reported) $393K $3.8M -$1.3M -$3.8M $3.8M
Operating Income (Adjusted) $2M -$608K $2.1M $1.1M -$12.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $111.2M $177.6M $176.7M $237M $225.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $108.4M $132.6M $134.6M $184M $186.2M
Gross Profit $2.7M $45M $42.1M $52.9M $39.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11.2M $12.1M $11.5M $16.7M $20.4M
Other Inc / (Exp) -$4.1M $25.4M $3.2M $9.5M -$27.2M
Operating Expenses $26.9M $30.8M $27M $30.7M $31.3M
Operating Income -$24.1M $14.2M $15.1M $22.2M $8.4M
 
Net Interest Expenses $1M $660K $966K $966K $832K
EBT. Incl. Unusual Items -$29.3M $38.9M $17.3M $30.7M -$19.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.4M $4.6M $19.6M $19.7M $9.8M
Net Income to Company -$36.7M $34.3M -$2.2M $11M -$29.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$36.7M $34.3M -$2.2M $11M -$29.5M
 
Basic EPS (Cont. Ops) -$0.26 $0.23 -$0.02 $0.05 -$0.13
Diluted EPS (Cont. Ops) -$0.26 $0.22 -$0.02 $0.05 -$0.13
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $848K $68.9M $40.3M $63.6M $12.8M
EBIT -$28.2M $39.5M $18.3M $31.6M -$18.8M
 
Revenue (Reported) $111.2M $177.6M $176.7M $237M $225.9M
Operating Income (Reported) -$24.1M $14.2M $15.1M $22.2M $8.4M
Operating Income (Adjusted) -$28.2M $39.5M $18.3M $31.6M -$18.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $77.7M $116.8M $128.2M $155M $175.4M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $71.2M $92.7M $98.3M $123.7M $141.1M
Gross Profit $6.5M $24.1M $29.9M $31.3M $34.3M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8.7M $8.4M $8.8M $9.5M $12M
Other Inc / (Exp) -$2M $22.8M $2.3M $9.7M -$28M
Operating Expenses $19.3M $22M $19.5M $22.3M $25.5M
Operating Income -$12.8M $2.1M $10.4M $8.9M $8.8M
 
Net Interest Expenses $1M $702K $945K $1.1M $1.1M
EBT. Incl. Unusual Items -$15.8M $24.2M $11.8M $17.5M -$20.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $3M $9.7M $13.6M $14.5M $12.2M
Net Income to Company -$18.8M $14.4M -$1.8M $3.1M -$32.5M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$18.8M $14.4M -$1.8M $3.1M -$32.5M
 
Basic EPS (Cont. Ops) -$0.13 $0.09 -$0.01 $0.01 -$0.14
Diluted EPS (Cont. Ops) -$0.13 $0.08 -$0.01 $0.01 -$0.14
Weighted Average Basic Share $445.9M $498.5M $541.8M $576M $716.4M
Weighted Average Diluted Share $445.9M $506.4M $548.2M $578M $716.4M
 
EBITDA $4M $44.2M $29.5M $41.3M $6.2M
EBIT -$14.8M $24.9M $12.7M $18.6M -$19.2M
 
Revenue (Reported) $77.7M $116.8M $128.2M $155M $175.4M
Operating Income (Reported) -$12.8M $2.1M $10.4M $8.9M $8.8M
Operating Income (Adjusted) -$14.8M $24.9M $12.7M $18.6M -$19.2M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $23.4M $61.1M $103.3M $83.4M $35.3M
Short Term Investments $69K $4.8M $11.2M $8.6M $5.1M
Accounts Receivable, Net $6.7M $8.8M $4.8M $4.4M $6.6M
Inventory $13.6M $16.6M $27.5M $19.2M $27.3M
Prepaid Expenses $3.3M $2.3M $5.1M -- --
Other Current Assets -- -- -- $17M $7.6M
Total Current Assets $63.3M $105M $161.8M $146.3M $100.8M
 
Property Plant And Equipment $89.7M $88.8M $122.9M $234.7M $315.4M
Long-Term Investments -- -- -- $1.4M --
Goodwill -- -- -- -- --
Other Intangibles $975K $492K $40K -- --
Other Long-Term Assets -- -- -- -- --
Total Assets $163.7M $210.6M $294M $399.4M $474.8M
 
Accounts Payable $19.8M $27.8M $32M $39.8M $46.1M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $3M $3.6M $4.1M $6M $3.9M
Current Portion Of Capital Lease Obligations $164K $173K $207K $261K $436K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $24.8M $34.6M $40.6M $52.7M $58.2M
 
Long-Term Debt $5.9M $6.1M $6.4M $8.5M $4.7M
Capital Leases -- -- -- -- --
Total Liabilities $40.9M $51.5M $56.6M $83.5M $88.5M
 
Common Stock $482.2M $517.7M $585.4M $657.9M $722.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $122.8M $159.1M $237.4M $315.9M $386.3M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $122.8M $159.1M $237.4M $315.9M $386.3M
 
Total Liabilities and Equity $163.7M $210.6M $294M $399.4M $474.8M
Cash and Short Terms $23.4M $65.9M $114.5M $92M $40.4M
Total Debt $8.9M $9.7M $10.5M $14.5M $8.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $44.9M $101.1M $69.2M $41M $54.9M
Short Term Investments $259K $7M $8.1M $6.2M $666K
Accounts Receivable, Net $7.8M $2.8M $3.6M $6.9M $9.1M
Inventory $17.6M $30.5M $36.5M $27.6M $24M
Prepaid Expenses $1.9M $5.1M $11.4M $37.5M --
Other Current Assets -- -- -- -- $5M
Total Current Assets $81.9M $161.1M $139.9M $131.4M $104.1M
 
Property Plant And Equipment $91M $108.8M $216.4M $277.7M $441.2M
Long-Term Investments -- -- $2M -- --
Goodwill -- -- -- -- --
Other Intangibles $614K -- -- -- --
Other Long-Term Assets -- -- -- -- $32.2M
Total Assets $182.6M $282.6M $372.7M $433.2M $611.4M
 
Accounts Payable $23M $26M $27.7M $43.4M $50.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $3.8M $3.1M $5.8M $4.3M $3.4M
Current Portion Of Capital Lease Obligations $166K $200K $145K $436K --
Other Current Liabilities -- -- -- -- $9.2M
Total Current Liabilities $28.1M $32.4M $38.3M $55.5M $74.7M
 
Long-Term Debt $6.9M $3.8M $8.2M $5.5M $81.9M
Capital Leases -- -- -- -- --
Total Liabilities $45.4M $45.6M $65.4M $88.5M $198.4M
 
Common Stock $515.8M $585.2M $657.8M $684.7M $780.2M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $137.2M $237M $307.3M $344.6M $413M
 
Total Liabilities and Equity $182.6M $282.6M $372.7M $433.2M $611.4M
Cash and Short Terms $45.2M $108.1M $77.3M $47.1M $55.6M
Total Debt $10.7M $6.9M $14M $9.8M $85.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$48.1M $1.2M $14M $6.2M $6.1M
Depreciation & Amoritzation -- -- -- $26.1M $28.8M
Stock-Based Compensation $3.2M $3M $3.6M $3.9M $3.6M
Change in Accounts Receivable $1.6M $2.1M $224K -$8.2M -$20.1M
Change in Inventories $511K -$2M -$11.1M $5.2M -$6.9M
Cash From Operations -$9.6M $39M $23.5M $55M $11.8M
 
Capital Expenditures $21.8M $25.5M $54.1M $109.7M $117.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$21.8M -$29.8M -$38M -$111.5M -$108M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $800K
Long-Term Debt Repaid -$1.6M -$3.4M -$3.7M -$5.3M -$6.3M
Repurchase of Common Stock -- -- -$2.4M -- --
Other Financing Activities -$716K -$1.4M -$1.3M -$4.8M -$9.8M
Cash From Financing $21.2M $27.5M $56.7M $36.8M $48.9M
 
Beginning Cash (CF) $33.4M $23.4M $61.1M $103.3M $83.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$10.2M $36.7M $42.1M -$19.7M -$47.3M
Ending Cash (CF) $23.4M $61.1M $103.3M $83.4M $35.3M
 
Levered Free Cash Flow -$31.4M $13.4M -$30.6M -$54.7M -$106M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $451K -$4.5M -$1.5M -$2.3M -$17.3M
Depreciation & Amoritzation -- -- -- $9.1M $7.4M
Stock-Based Compensation $793K $725K $760K $864K $564K
Change in Accounts Receivable -$3M -$1.2M $950K -$3M $1.9M
Change in Inventories $89K -$5.5M -$2M $1.8M -$303K
Cash From Operations $15.6M -$153K $7.4M $613K $7M
 
Capital Expenditures $8.6M $23.4M $53M $31.7M $48.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$8.5M -$23.4M -$52.8M -$23.7M -$42.2M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -$500K $24.3M
Long-Term Debt Repaid -$892K -$889K -$1.3M -$1.6M -$958K
Repurchase of Common Stock -- -$189K $1.9M -- --
Other Financing Activities -$96K -$27K -$2M -- -$602K
Cash From Financing $6.5M -$400K -$1.6M $20.4M $21.7M
 
Beginning Cash (CF) $30.5M $125.2M $116.2M $43.5M $68.1M
Foreign Exchange Rate Adjustment $833K -$190K -$84K $213K $357K
Additions / Reductions $13.6M -$23.9M -$46.9M -$2.8M -$13.5M
Ending Cash (CF) $44.9M $101.1M $69.2M $41M $54.9M
 
Levered Free Cash Flow $7M -$23.5M -$45.6M -$31.1M -$41.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$36.7M $34.3M -$2.2M $11M -$29.5M
Depreciation & Amoritzation -- -- -- -- $31.6M
Stock-Based Compensation $3M $3.5M $4M $3.5M $3.6M
Change in Accounts Receivable $4.1M $3.6M -- -$13.9M -$13.9M
Change in Inventories $6.9M -$14.7M -- $6.2M $3.5M
Cash From Operations $17M $32M $28.7M $49.5M $30.7M
 
Capital Expenditures $25.4M $45.4M $96.8M $104.5M $191M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$25.2M -$33.8M -$98.4M -$94.8M -$181.1M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- $85.8M
Long-Term Debt Repaid -$3.1M -$4M -$4.6M -$6.5M -$4.7M
Repurchase of Common Stock -- -$2.4M -- -- --
Other Financing Activities -$1.3M -$1.6M -$4.8M -$275K -$10.9M
Cash From Financing $30.8M $57.3M $37.6M $17.5M $164.5M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $22.6M $55.5M -$32.2M -$27.8M $14.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$8.4M -$13.4M -$68.1M -$55.1M -$160.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$18.8M $14.4M -$1.8M $3.1M -$32.5M
Depreciation & Amoritzation -- -- -- $22.7M $25.4M
Stock-Based Compensation $2.4M $2.9M $3.3M $2.9M $2.9M
Change in Accounts Receivable -- $1.5M -$2.4M -$8.1M -$1.9M
Change in Inventories -- -$12.7M -$8.5M -$7.5M $2.9M
Cash From Operations $12.3M $5.4M $10.6M $5.1M $24M
 
Capital Expenditures $18.9M $38.8M $81.5M $76.3M $149.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$18.8M -$22.8M -$83.2M -$66.6M -$139.6M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $0 $85M
Long-Term Debt Repaid -$2.3M -$2.9M -$3.7M -$4.9M -$3.3M
Repurchase of Common Stock -- -$2.4M -- -- --
Other Financing Activities -$1.1M -$1.3M -$4.8M -$294K -$1.3M
Cash From Financing $27.8M $57.5M $38.5M $19.3M $134.8M
 
Beginning Cash (CF) $68.9M $272.3M $370.5M $188.5M $138.3M
Foreign Exchange Rate Adjustment $213K -$126K $55K -$204K $511K
Additions / Reductions $21.3M $40.1M -$34.2M -$42.2M $19.1M
Ending Cash (CF) $90.4M $312.3M $336.4M $146.1M $157.9M
 
Levered Free Cash Flow -$6.6M -$33.4M -$70.9M -$71.3M -$125.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 5.73% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 7.2% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.6% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock